Wednesday, April 22, 2015

Oncology center and US software company closed agreements … – swissinfo.ch

HAVANA (Reuters) – A cancer research center and a software company, both from the USA, reached agreements with Cuban partners during the two-day trade mission to Cuba, under the leadership of New York Governor Andrew Cuomo, the first trip of its kind since the rapprochement between former adversaries countries.

The Cancer Center Roswell Park, Bufallo in New York, on Tuesday signed an agreement with the Molecular Immunology Center of Cuba to develop a vaccine against lung cancer with clinical tests to be made in the USA, said the executive director of the Roswell Park, Cadence Johnson.

Now the software company Infor Global Solutions, headquartered in New York, said he had done according to a Cuban partner, this time software for resale in Cuba, said Chief Executive Officer Charles Phillips.

Both announcements were made at the airport, just before Cuomo and a delegation of 18 executives and academic leaders embark back to New York.

Cuomo, a Democrat, is the first US governor to visit Cuba since US President Barack Obama, and Cuba, Raul Castro announced that they would restore diplomatic relations and work to normalize trade and travel between the two countries, after more than half a century of hostility and confrontation.

Obama has used his executive authority to relieve some parts of the US economic embargo against Cuba, but need support Congress, controlled by Republicans, to completely suspend the measure and normalize trade relations.

Among the members of the trade mission were executives of JetBlue Airways, Pfizer and MasterCard.

Cuomo said the mission was intended to help New York companies to be “First going through the gates “and close trade agreements, once relieved tensions in the relationship between the US and Cuba.

“This agreement establishes a collaboration between our two institutions to develop a vaccine against lung cancer,” said Cadence, director of the Cancer Center Roswell Park on the vaccine developed by scientists at the center of Cuban research.

Phillips did not disclose the name of his new Cuban partner, but said an agreement was reached during a dinner the night before.

“We are impressed with the level of technology and expertise they have in health technology,” he said.

(Daniel Trotta Reporting)

LikeTweet

No comments:

Post a Comment